Listings in the U.S. and Europe
QIAGEN’s common shares have been registered and traded in the United States since 1996 on the NASDAQ Global Select Market (NASDAQ National Market prior to July 2006) and in Germany since 1997 on the Frankfurt Stock Exchange (and the Prime Standard segment since its launch in 2003). Dual listing on NASDAQ and the Frankfurt Stock Exchange offers advantages for QIAGEN, our shareholders and employees since dual listing increases the potential market opportunity and increases liquidity for our shares. Unlike American Depositary Receipts (ADRs), QIAGEN’s shares provide equal corporate rights for all shareholders and can be traded on either exchange, in U.S. dollars or euros.
|Average daily trading volume (in million shares)||1.0||0.9|
|Frankfurt Stock Exchange (XETRA)||2016||2015|
|Average daily trading volume (in million shares)||0.4||0.4|
QIAGEN is one of the largest and most prominent constituents of Germany’s TecDAX, a stock index that tracks the 30 largest German companies from the technology sector not included in the benchmark DAX index. As of December 31, 2016, QIAGEN was among the top three companies in the TexDAX based on market capitalization.
QIAGEN is also a member of the U.S. large-cap Russell 1000 index and the broad market Russell 3000 index, which measures performance of the 3,000 largest companies in the U.S. The Russell 1000 index is a subset of the Russell 3000 index and includes 1,000 of the largest securities based on a combination of their market capitalization and current index membership.
Furthermore, QIAGEN shares are included in other U.S. and European stock market indexes.
|Key share data||2016||2015|
|Total equity (in $ thousands)||2,607,096||2,568,070|
|Issued shares (in thousands)||239,707||239,707|
|Outstanding shares at December 31 (in thousands)||234,561||233,006|
|Weighted-average number of common shares outstanding - basic (in thousands)||234,800||233,483|
|Weighted-average number of common shares outstanding - diluted (in thousands)||238,993||238,647|
|Year-end market capitalization (in $ million)||6,572||6,443|
|Year-end market capitalization (in € million)||6,258||5,852|